Relation deploys its cutting edge machine learning technology to find hitherto unknown relationships between drugs and disease processes. They use this to generate predictions for novel drug candidates, with a view to rapidly progressing them through to the clinic.
They work with some of the world’s leading researchers, with access to collaborators and advisors at Oxford, Cambridge, Imperial, MILA, The Alan Turing Institute, UCL, and University of Dundee, as well as some of the most consistently successful drug developers in the history of Pfizer, Astra Zeneca, and AbbVie.
Their core domain focus is in diseases of ageing including immunology, oncology, and degenerative diseases. However, they are currently most focused on the COVID-19 crisis bringing their science and network to bear on this generational challenge.See more